Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
CapEx to Revenue
4.92%
Quarterly · Period ending:
BIO CapEx to Revenue
Latest reported4.92%period ending
Latest reported4.92%period ending
BIO Quarterly CapEx/Revenue (0.00% → 4.92%)
Latest values, visible window
High-resolution chart · PNG
BIO capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 4.9155% | |
| 5.0667% | |
| 6.607% | |
| 4.8545% | |
| 7.0135% | |
| 5.8763% | |
| 6.4278% | |
| 9.7947% | |
| 6.6222% | |
| 6.5774% | |
| 6.2017% | |
| 6.9719% | |
| 5.0857% | |
| 5.2782% | |
| 6.4266% | |
| 4.0504% | |
| 2.5082% | |
| 4.725% | |
| 5.9009% | |
| 4.6353% | |
| 3.2668% | |
| 2.6895% | |
| 4.9548% | |
| 3.0865% | |
| 3.3743% | |
| 3.7945% | |
| 3.4588% | |
| 5.5457% | |
| 3.8794% | |
| 4.2653% | |
| 8.724% | |
| 4.0456% | |
| 4.6389% | |
| 4.9289% | |
| 4.2024% | |
| 3.7725% | |
| 5.8532% | |
| 7.8656% | |
| 7.917% | |
| 7.7559% | |
| 6.11% | |
| 5.3685% | |
| 4.9047% | |
| 5.2766% | |
| 6.3629% | |
| 6.0038% | |
| 6.7074% | |
| 5.175% | |
| 6.3247% | |
| 6.8596% | |
| 4.9519% | |
| 4.0272% | |
| 4.6699% | |
| 6.9177% | |
| 6.9892% | |
| 7.4514% | |
| 8.2346% | |
| 7.1768% | |
| 6.4794% | |
| 4.8347% | |
| 4.7518% | |
| 3.6923% | |
| 6.159% | |
| 4.47% | |
| 4.237% | |
| 3.9825% | |
| 4.0398% | |
| 3.8186% | |
| 4.7024% | |
| 4.6559% | |
| 5.0629% | |
| 5.855% | |
| 4.5404% | |
| 4.6708% | |
| 3.1885% | |
| 5.4948% | |
| 5.318% | |
| 3.5072% | |
| 4.3453% | |
| 4.3404% | |
| 4.259% | |
| 3.6706% | |
| 3.1755% | |
| 3.0739% | |
| 2.6835% | |
| 3.267% | |
| 6.128% | |
| 4.8561% | |
| 6.0028% | |
| 5.0318% | |
| 8.0135% | |
| 9.0039% | |
| 5.9082% | |
| 4.4644% | |
| 4.5128% | |
| 5.4625% | |
| 4.9059% | |
| 4.017% | |
| 4.781% | |
| 6.6732% |